TECHNICAL FIELD
[0001] This invention relates to liquid detergent compositions containing enzymes. More
specifically, this invention pertains to liquid detergent compositions containing
a detersive surfactant, a proteolytic enzyme, a peptide aldehyde, and calcium ions.
The combination of peptide aldehyde and calcium ions act to provide synergistic protease
inhibitor benefits.
BACKGROUND OF THE INVENTION
[0002] Protease-containing liquid aqueous detergents are well-known, especially in the context
of laundry washing. A commonly encountered problem in such protease-containing liquid
aqueous detergents is the degradation phenomenon by the proteolytic enzyme of second
enzymes in the composition, such as amylase, lipase, and cellulase, or on the protease
itself. As a result, the stability of the second enzyme or the protease itself in
the detergent composition is affected and the detergent composition consequently performs
less well.
[0003] In response to this problem, it has been proposed to use various protease inhibitors
or stabilizers. For instance, various references have proposed the use of the following
compounds to aid in the stabilization of enzymes: benzamidine hydrochloride, lower
aliphatic alcohols or carboxylic acids, mixtures of a polyol and a boron compound,
aromatic borate esters, and calcium, particularly calcium formate. Recently, it was
discovered that certain peptide aldehydes act to stabilize protease enzyme.
[0004] Although these compounds have been used to varying success in liquid detergents,
they are not free of problems. For example peptide aldehydes are rather expensive
and create complexities for the formulators, especially for liquid detergents. Other
inhibitors such as calcium and boric acids are less expensive but do not stabilize
enzymes as well as peptide aldehydes. It is thus an object of the present invention
to provide a protease inhibitor system which is economical, effective and suitable
for use in a liquid detergent composition.
[0005] In response to this object, the present invention proposes to use a combination of
calcium ions and peptide aldehydes as reversible protease inhibitors in aqueous liquid
detergent compositions. The presence of both calcium and peptide aldehyde provides
a synergistic stabilization of the protease. This novel combination provides the formulator
added flexibility in designing a stabilization system. The levels of peptide aldehyde
and calcium can be adjusted to deliver the most cost effective formula and to minimize
product stability problems that often arise from the presence of divalent ions in
a liquid detergent matrix.
[0006] In particular, the present invention allows for the use of very low levels of peptide
aldehydes in the liquid detergent compositions herein. This is particularly critical
in the formulation of relatively inexpensive, concentrated liquid detergent compositions
which are encompassed by the present invention.
[0007] Because the combination of calcium and peptide aldehydes are so efficient in inhibiting
proteases, another advantage of the present invention is that even enzymes which are
highly sensitive to proteolytic degradation can now be incorporated in liquid detergent
compositions comprising a protease. Moreover, it has also been discovered that the
increased stability of the protease enzyme allows for improved skincare benefits.
These benefits include softening of the skin and hands and less drying from exposure
of the hands to the dishwashing liquor.
BACKGROUND ART
[0008] It has been proposed to use various protease inhibitors or stabilizers. For instance,
US 4,566,985 proposes to use benzamidine hydrochloride; EP 376 705 proposes to use
lower aliphatic alcohols or carboxylic acids; EP 381 262 proposes to use a mixture
of a polyol and a boron compound; and EP91870072.5 proposes to use aromatic borate
esters. See also U.S. Pat. No. 5,030,378 issued July 9, 1991. Also see US4,261,868;
US4,404,115; US4,318,818; and EP130,756.
[0009] The use of peptide derivatives for the inhibition of proteins appears to have been
disclosed in therapeutic applications. EP 293 881 discloses the use of peptide boronic
acids as inhibitors of trypsin-like serine proteases. EP 185 390 and US 4,399,065
disclose the use of certain peptide aldehydes derivatives for the inhibition of blood
coagulation. J 90029670 discloses the use of optically active alpha amino aldehydes
for the inhibition of enzymes in general. See also "Inhibition of Thrombin and Trypsin
by Tripeptide Aldehydes",
Int. J. Peptide Protein Res., Vol 12 (1978), pp. 217-221; Gaal, Bacsy & Rappay, and "Tripeptide Aldehyde Protease
Inhibitors May Depress in Vitro Prolactin and Growth Hormone Release"
Endocrinology, Vol. 116, No. 4 (1985), pp. 1426-1432; Rappay, Makara, Bajusz & Nagy. Certain peptide
aldehydes have also been disclosed in EP-A-473 502 for inhibiting protease-mediated
skin irritation.
[0010] In particular see EP185,390, WO94/04651, published 3 March 1994, WO94/04652, published
3 March 1994, EP 583,536, published February 23,1994, EP 583,535, published February
3, 1994, EP 583,534, published February 23, 1994, WO 93/13125, published July 8, 1993,
US4,529,525, US4,537,706, US4,537,707, and US5,527,487.
[0011] JP 62 269 689 describes a method for stabilising enzymes in detergent compositions
by adding a reversible inhibitor for the enzyme and optionally adding calcium salt.
WO 92/03529 discloses a detergent composition comprising a protease and one or more
enzymes, as well as a reversible protease inhibitor of the peptide or protein type.
SUMMARY OF THE INVENTION
[0012] The invention herein is a liquid detergent composition comprising:
a) an effective amount of a detersive surfactant;
b) an active proteolytic enzyme;
c) a source of calcium ions; other than a compound of the formula RO(A)mSO3 M; R, A and M, m are described in claim 1 and
d) a peptide aldehyde having the formula:
Z-B-NH-CH(R)-C(O)H
wherein B is a peptide chain comprising from 1 to 5 amino acid moieties; Z is
an N-capping moiety selected from the group consisting of phosphorarnidate [(R"O)
2(O)P-], sulfenamide [(SR")
2-], sulfonamide [(R"(O)
2S-], sulfonic acid [SO
3H], phosphinamide [(R")
2(O)P-], sulfamoyl derivative [R"O(O)
2S-], thiourea [(R")
2N(O)C-], thiocarbamate [R"O(S)C-], phosphonate [R"-P(O)OH], amidophosphate [R"O(OH)(O)P-],
carbamate (R"O(O)C-), and urea (R"NH(O)C-), wherein each R" is independently selected
from the group consisting of straight or branched C
1-C
6 unsubstituted alkyl, phenyl, C
7-C
9 alkylaryl, and cycloalkyl moieties, wherein the cycloalkyl ring may span C
4-C
8 and may contain one or more heteroatoms selected from the group consisting of O,N,and
S (preferred R" is selected from the group consisting of methyl, ethyl, and benzyl);
and R is selected from the group consisting of straight or branched C
1 - C
6 unsubstituted alkyl, phenyl, and C
7 - C
9 alkylaryl moieties.
[0013] Without being limited by theory, it is believed that the combined source of calcium
ion and peptide aldehyde provides more than additive stability to the proteolytic
enzyme.
[0014] Preferably, the liquid detergent compositions herein comprise, by weight of composition:
a) from 1 to 95%, preferably from 8% to 70%, of said detersive surfactant;
b) from 0.0001% to 5%, preferably from 0.0003% to 0.1%, of an active proteolytic enzyme;
c) from 0.00001% to 5%, preferably from 0.0001% to 1%, more preferably from 0.0006%
to 0.5%, of a peptide aldehyde as described hereinbefore; and
d) from 0.01% to 1%, preferably from 0.05% to 0.5%, of calcium ion.
[0015] The proteolytic enzyme useful herein is preferably a subtilisin-type protease and
may be selected from the group consisting of Alcalase®, Subtilisin BPN', Protease
A, Protease B, and mixtures thereof.
[0016] The source of calcium ion for use herein is preferably selected from calcium formate,
calcium xylene sulfonate, calcium chloride, calcium acetate, calcium sulfate. and
mixtures thereof.
[0017] The dishcare compositions herein may contain further detersive adjuncts, including
but not limited to, one or more of the following: suds boosters, chelants, polyacrylate
polymers, dispersing agents, dyes, perfumes, processing aids, and mixtures thereof.
Moreover for dishcare compositions, the liquid detergent compositions may further
comprise an effective amount of amylase enzyme. Additionally, the dishcare compositions
may optionally comprise an effective amount of a source of boric acid and a diol.
Typically dishcare compositions will optionally, but preferably, comprise from about
0.25% to about 10%, preferably from about 0.5% to about 5%, more preferably from about
0.75% to about 3%, by weight of boric acid or a compound capable of forming boric
acid and a diol, e.g. 1,2-propanediol.
[0018] In a preferred embodiment for heavy duty detergent compositions useful in laundry
care, the liquid detergent composition further comprises an effective amount one or
more of the following enzymes: lipase, amylase, cellulase, and mixtures thereof. Preferably
for laundry compositions, the second enzyme is lipase and is obtained by cloning the
gene from
Humicola Lanuginosa and expressing the gene in
Aspergillus Oryzae. Lipase is utilized in an amount of from about 10 to about 18000 lipase units per
gram, preferably from about from about 60 to about 6000 units per gram.
[0019] In another preferred composition useful for laundry care, the second enzyme is a
cellulase derived from
Humicola Insolens and is utilized in an amount of from about 0.0001% to about 0.1% by weight of the
total composition of said cellulase.
[0020] The compositions herein may contain further detersive adjuncts, including but not
limited to, one or more of the following: suds boosters, builders, soil release polymers,
polyacrylate polymers, dispersing agents, dye transfer inhibitors, dyes, perfumes,
processing aids, brighteners, and mixtures thereof. Additionally, for laundrycare
compositions, the detersive surfactant is typically present in an amount of from 10%
to 70%, by weight of total composition. Moreover, the laundry compositions may optionally
comprise an effective amount of a source of boric acid and a diol. Typically laundry
compositions will optionally, but preferably, comprise from about 0.25% to about 10%,
preferably from about 0.5% to about 5%, more preferably from about 0.75% to about
3%, by weight of boric acid or a compound capable of forming boric acid and a diol,
e.g. 1,2-propanediol.
[0021] All percentages and proportions herein are by weight, and all references cited are
hereby incorporated by reference, unless otherwise specifically indicated.
DETAILED DESCRIPTION OF THE INVENTION
[0022] Definitions - The present detergent compositions comprise an "effective amount" or a "stain removal-improving
amount" of individual components defined herein. An "effective amount" or "stain removal-improving
amount" is any amount capable of measurably improving soil cleaning or stain removal
from a substrate, i.e., soiled fabric or soiled dishware, when it is washed by the
consumer. In general, this amount may vary quite widely.
[0023] By "synergy" or "more than additive" as used herein is meant that the enzyme stability
benefit when the calcium and peptide aldehydes are combined is greater than the sum
of the individual benefits obtained when only one of the components is present in
a detergent composition.
[0024] The liquid aqueous detergent compositions according to the present invention comprise
four essential ingredients: (A) a peptide aldehyde or a mixture thereof, (B) a proteolytic
enzyme or a mixture thereof, (C) a detersive surfactant, and (D) calcium ion. The
compositions according to the present invention preferably further comprise (E) a
detergent-compatible second enzyme or a mixture thereof, and may further comprise
(F) other optional ingredients.
[0025] Peptide aldehydes - The detergent compositions according to the present invention comprise, as a first
essential ingredient, a peptide aldehyde having the formula:
Z-B-NH-CH(R)-C(O)H
wherein B is a peptide chain comprising from 1 to 5 amino acid moieties; Z is an
N-capping moiety selected from the group consisting of phosphoramidate [(R"O)
2(O)P-], sulfenamide [(SR")
2-], sulfonamide [(R"(O)
2S-], sulfonic acid [SO
3H], phosphinamide [(R")
2(O)P-], sulfamoyl derivative [R"O(O)
2S-], thiourea [(R")
2N(O)C-], thiocarbamate [R"O(S)C-], phosphonate [R"-P(O)OH], amidophosphate [R"O(OH)(O)P-],
carbamate (R"O(O)C-), and urea (R"NH(O)C-), wherein each R" is independently selected
from the group consisting of straight or branched C
1-C
6 unsubstituted alkyl, phenyl, C
7-C
9 alkylaryl, and cycloalkyl moieties, wherein the cycloalkyl ring may span C
4-C
8 and may contain one or more heteroatoms selected from the group consisting of O,N,and
S (preferred R" is selected from the group consisting of methyl, ethyl, and benzyl);
and R is selected from the group consisting of straight or branched C
1 - C
6 unsubstituted alkyl, phenyl, and C
7 - C
9 alkylaryl moieties.
[0026] Preferred R moieties are selected from the group consisting of methyl, iso-propyl,
sec-butyl, iso-butyl, -C
6H
5, -CH
2-C
6H
5, and -CH
2CH
2-C
6H
5, which respectively may be derived from the amino acids Ala, Val, Ile, Leu, PGly
(phenylglycine), Phe, and HPhe (homophenylalanine) by converting the carboxylic acid
group to an aldehyde group. While such moieties are therefore not amino acids (and
they may or may not have been synthesized from an amino acid precursor), for purposes
of simplification of the exemplification of inhibitors useful here, the aldehyde portion
of the inhibitors are indicated as derived from amino acids by the addition of "H"
after the analogous amino acid [e.g., "-AlaH" represents the chemical moiety "-NHCH(CH
3)C(O)H"].
[0027] Preferred B peptide chains are selected from the group consisting of peptide chains
having the amino acid sequences according to the general formula:
Z-A
5-A
4-A
3-A
2-A
1-NH-CH(R)-C(O)H
such that the following amino acids, when present, are :
A1 is selected from Ala, Gly;
A2 , if present, is selected from Val, Ala, Gly, Ile;
A3 , if present, is selected from Phe, Leu, Val, Ile;
A4, if present, is any amino acid, but preferably is selected from Gly, Ala;
A5 , if present, is any amino acid, but preferably is Gly, Ala, Lys.
[0028] The present invention aldehydes may be prepared from the corresponding amino acid
whereby the C-terminal end of said amino acid is converted from a carboxylic group
to an aldehyde group. Such aldehydes may be prepared by known processes, for instance
as described in US 5015627, EP 185 390, EP 583,534, and DE 32 00 812.
[0029] While not wanting to be bound by theory it is believed that the peptide aldehydes
according to the present invention bind to the proteolytic enzyme in the liquid detergent
composition, thereby inhibiting said proteolytic enzyme. Upon dilution in water, the
proteolytic activity is restored by dissociation of the proteolytic enzyme/peptide
aldehyde complex.
[0030] The N-terminal end of said protease inhibitors according to the present invention
is protected by one of the N-capping moiety protecting groups selected from the group
consisting of carbamates, ureas, sulfonamides, phosphonamides,thioureas, sulfenamides,
sulfonic acids, phosphinamides, thiocarbamates, amidophosphates, and phosphonamides.
However, in a highly preferred embodiment of the present invention, the N-terminal
end of said protease inhibitor is protected by a methyl, ethyl or benzyl carbamate
[CH
3O-(O)C-; CH
3CH
2O-(O)C-; or C
6H
5CH
2O-(O)C-], methyl, ethyl or benzyl urea [CH
3NH-(O)C-; CH
3CH
2NH-(O)C-; or C
6H
5CH
2NH-(O)C-], methyl, ethyl or benzyl sulfonamide [CH
3SO
2-; CH
3CH
2SO
2-; or C
6H
5CH
2SO
2-], and methyl, ethyl or benzyl amidophosphate [CH
3O(OH)(O)P-; CH
3CH
2O(OH)(O)P-; or C
6H
5CH
2O(OH)(O)P-] groups.
[0031] Synthesis of N-capping groups can be found in the following references:
Protective Groups in Organic Chemistry, Greene, T., Wuts, P., John Wiley & Sons, New York, 1991, pp 309-405; March, J,
Advanced Organic Chemistry, Wiley Interscience, 1985, pp. 445, 469, Carey, F. Sundberg, R.,
Advanced Organic Chemistry, Part B, Plenum Press, New York, 1990, pp. 686-89; Atherton, E., Sheppard, R.,
Solid Phase Peptide Synthesis, Pierce Chemical, 1989, pp. 3-4; Grant, G.,
Synthetic Peptides, W. H. Freeman & Co. 1992, pp. 77-103; Stewart, J., Young, J.,
Solid Phase Peptide Synthesis, 2nd Edition, IRL Press, 1984, pp. 3,5,11,14-18, 28-29. Bodansky, M.,
Principles of Peptide Synthesis, Springer-Verlag, 1988, pp. 62, 203, 59-69; Bodansky, M.,
Peptide Chemistry, Springer-Verlag, 1988, pp. 74-81, Bodansky, M., Bodansky, A.,
The Practice of Peptide Synthesis, Springer-Verlag, 1984, pp. 9-32.
[0032] Examples of peptide aldehydes for use herein are: CH
3SO
2Phe-Gly-Ala-Leu-H, CH
3SO
2Val-Ala-Leu-H, C
6H
5CH
2O(OHXO)P-Val-Ala-Leu-H, CH
3CH
2SO
2-Phe-Gly-Ala-Leu-H, C
6H
5CH
2SO
2-Val-Ala-Leu-H, C
6H
5CH
2O(OH)(O)P-Leu-Ala-Leu-H, C
6H
5CH
2O(OH)(O)P-Phe-Ala-Leu-H, and CH
3O(OH)(O)P-Leu-Gly-Ala-Leu-H.
[0033] In the Synthesis Examples hereinafter methods are disclosed to synthesize certain
of these peptide aldehydes.
Synthesis Example 1
Synthesis of the tetrapeptide aldehyde Moc-Ala-Phe-Gly-Ala-LeuH
[0034]
(a) Ala-Leu-OMe.HCL: To a solution of 3.0 g (14.83 mmol) Ala-Leu-OH, which is dissolved
in 50 ml of MeOH and cooled to 0°C, is added 2.43 ml (33.36 mmol) thionyl chloride
dropwise. This solution is stirred overnight at room temperature and evaporated to
dryness providing quantitative recovery of the desired product.
(b) Cbz-Gly-Ala-Leucine methyl ester: To a solution of 0.414 g (1.98 mmol) Cbz-Gly-OH
and 0.500 g (1.98 mmol) Ala-Leu-OMe.HCl in CH2Cl2 is add 0.607 ml TEA followed immediately by 0.355 ml DEPC. The solution is stirred
overnight, evaporated, and the residue partitioned between EtOAc and 1N HCl. The organic
phase is washed successively with saturated NaHCO3 and saturated NaCl, dried (MgSO4)and evaporated to afford 0.650 g of pure product.
(c) Moc-Ala-Phe-OH: To a solution of 1.0 g (4.23 mmol) Ala-Phe which is dissolved
in 4.23 ml 1N NaOH and cooled to 0°C, 0.419 g (4.44 mmol) is aded methyl chloroformate
dropwise. At the same time, in a separate addition funnel, an additional 4.23 ml 1N
NaOH is added such that the pH is maintained between 9.0-9.5. After addition is complete
the reaction is stirred 30 minutes at 0°C and 2 h at room temperature. At this point
the solution is cooled to 0° and the pH adjusted to 9.5. This basic solution is washed
with EtOAc (1X, 100 ml). The aqueous (0°C) is then adjusted to pH = 2.5 (2N HCl) and
extracted with EtOAc (3X, 50 ml), dried (MgSO4) and evaporated to provide 1.07 g pure product.
(d) Moc-Ala-Phe-Gly-Ala-Leu-OMe: To a solution of 0.500 g (1.22 mmol) Cbz-Gly-Ala-Leucine
methyl ester in 10 ml MeOH is added 0.100 g 10% Pd/C. This solution is hydrogenated
in the presence of 0.600 ml 4.0M HCl/Dioxane (under balloon pressure) for 1 h, filtered
through celite and evaporated. This residue is suspended in CH2Cl2, 0.342 ml (2.45 mmol) TEA is added followed by 0.359 g (1.22 mmol) Moc-Ala-Phe-OH
and 0.219 ml (1.34 mmol) DEPC. After stirring overnight the solvent is evaporated,
the residue partitioned between EtOAc and 1N HCl and washed successively with saturated
NaHCO3 and NaCl. Drying, evaporation and column chromatography yield 0.450 g of the pure
product.
(e) Moc-Ala-Phe-Gly-Ala-Leucinol: A solution is prepared by dissolving 0.182 g (1.64
mmol) CaCl2 in a mixture of 4 ml ethanol and 2 ml THE. This mixture is cooled to -15°C and 0.450
g (0.820 mmol) Moc-Ala-Phe-Gly-Ala-Leu-OMe is added followed by 0.124 g (3.28 mmol)
NaBH4. The reaction is stirred for 2 h and quenched with 10 ml 1N HCl. The solvents are
evaporated and the remaining aqueous layer partitioned with EtOAc. The organic phase
is then washed with saturated NaHCO3 and saturated NaCI. Drying (MgSO4), evaporation and chromatography affords 0.256 g of pure product.
(f) Moc-Ala-Phe-Gly-Ala-LeuH: A solution is prepared by adding 0.623 g (1.47 mmol)
Dess-Martin periodinane to 1.8 L CH2Cl2 followed by stirring for 10 minutes. This solution is then cooled to 0°C and 0.256
g (0.490 mmol) Etoc-Phe-Gly-Ala-Leucinol is added in one portion. The reaction is
continued for 2 h and poured into a solution consisting of 2.55 g (10.47 mmol) Na2S2O3 in 30 ml saturated NaHCO3. After stirring for 10 minutes the mixture is extracted with EtOAc (2X, 50 ml). The
combined extracts are dried (MgSO4), evaporated, and chromatographed on silica to provide 0.125 g of pure product.
Synthesis Example 2:
Synthesis of the tripeptide aldehyde Etoc-Phe-Gly-Ala-LeuH
[0035]
(a) Ala-Leu-OMe.HCL: To a solution of 450 g (2.20 mol) Ala-Leu-OH, which is dissolved
in 4.5 L of MeOH and cooled to 0°C, is added 178.6 ml (4.95 mol) of thionyl chloride
dropwise. The solution is stirred overnight at room temperature and evaporated to
dryness providing 543 g (97.1% yield) of the desired product to be used as is.
(b) Etoc-Phe-Gly-OH: To a solution of 450 g (2.03 mol) Phe-Gly which is dissolved
in 2026 ml 1N NaOH and cooled to 0°C, is added methyl chloroformate (3.1 ml, 40.0
mmol) dropwise. At the same time, in a separate addition funnel, an additional 2026
ml 1N NaOH is added such that the pH is maintained between 9.0-9.5. After addition
is complete the reaction is stirred 30 minutes at 0°C and 2 h at room temperature.
At this point the solution is cooled to 0° and the pH adjusted to 9.5. This basic
solution is washed with EtOAc (1X, 4 L). The aqueous (0°C) is then adjusted to pH
= 2.5 (2N HCl) and extracted with EtOAc (3X, 8L), dried (MgSO4), filtered, and the solvent removed to afford 546 g (91.3% yield) pure product.
(c) Etoc-Phe-Gly-Ala-Leu-OMe: To a solution of 470 g (1.86 mol) Etoc-Phe-Gly-OH and
546 g (1.86 mol) Ala-Leu-OMe.HCl in 8 liters CH2Cl2 570 ml (4.09 mol) TEA is added followed by 310.4 ml (2.046 mol) DEPC. After stirring
overnight the solvent is evaporated and replaced with EtOAc (4 L). This solution is
washed consecutively with 2 liters each of 2N HCl, sat'd NaHCO3 and sat'd NaCI. The organic phase is then dried (MgSO4), filtered and evaporated to yield 916 g (93% yield) of the desired material.
(d) Etoc-Phe-Gly-Ala-Leucinol: To a solution of 45.10 g (0.406 mol) CaCl2 in 1 L ethanol and 1 L THF 100 g (0.203 mol) of Etoc-Phe-Gly-Ala-Leu-OMe is added
and the mixture cooled to -15°C. To this solution 30.7 g (0.812 mmol) NaBH4 is carefully added followed by stirring for 2 h. Subsequently the reaction is quenched
with 100ml 0. IN HCl. This solution is transfered to 4 L of 1N HCl and extracted with
EtOAc (3X, 2.75 L). The combined EtOAc layers are washed with 4 L saturated NaHCO3, dried (MgSO4) and evaporated. Trituration (twice) with ether (4 L) provides 69.2 g (73.4% yield)
of the product.
(e) Etoc-Phe-Gly-Ala-LeuH: A solution is prepared by adding 165.4 g (0.39 mol) Dess-Martin
periodinane to 1.8 L CH2Cl2 followed by stirring for 10 minutes. This solution is then cooled to 0°C and 60 g
(0.13 mol) Etoc-Phe-Gly-Ala-Leucinol added in one portion. The reaction is continued
for 105 minutes and poured into a solution consisting of 6 L H2O, 393 g NaHCO3 and 431.7 g (1.74 mol) Na2S2O3. After stirring for 10 minutes the phases are separated and 2 additional extractions
(1.5 L each) with CH2Cl2 are performed. The combined extracts are dried (MgSO4), evaporated, and triturated with (2X, 1L) ether to provide 51.7 g (86.2% yield)
of the product.
Synthesis Example 3:
Synthesis of the dipeptide aldehyde Moc-Gly-Ala-LeuH
[0036]
(a) Ala-Leu-OMe.HCL: To a solution of 3.0 g (14.83 mmol) Ala-Leu-OH, which is dissolved
in 50 ml of MeOH and cooled to 0°C, is added 2.43 ml (33.36 mmol) of thionyl chloride
dropwise. The solution is stirred overnight at room temperature and evaporated to
dryness. providing a quantitative yield of the desired product.
(b) Cbz-Gly-Ala-Leucine methyl ester: To a solution of 0.414 g (1.98 mmol) Cbz-Gly-OH
and 0.500 g (1.98 mmol) Ala-Leu-OMe.HCl in CH2Cl2 0.607 ml TEA is added followed immediately by 0.355 ml DEPC. The solution is stirred
overnight and then evaporated. The residue is partitioned between EtOAc and 1N HCl,
the organic phase is washed with saturated NaHCO3 and saturated NaCl, dried (MgSO4) and evaporated providing 650 mg of pure product.
(c) Moc-Gly-Ala-Leucine methyl ester: To a solution of 2.0 g (4.90 mmol) Cbz-Gly-Ala-Leucine
methyl ester which is dissolved in 20 ml MeOH is added 0.200 g 10% Pd/C. This is hydrogenated
in the presence of 2.45 ml (9.81 mmol) 4.0M HCl/Dioxane for 2 h after which the reaction
is thoroughly outgassed and filtered hrough Celite to remove the catalyst Evaporation
of the MeOH affords 1.45 g of pure product which is suspended in 45 ml CH2Cl2 and cooled to 0°C. To this solution 1.45 ml (3.25 mmol) TEA is added followed by
0.362 ml methyl chloroformate. After stirring overnight the CH2Cl2 is evaporated and the residue partitioned between EtOAc and 1N HCl. The organic phase
is separated and washed sequentially with NaHCO3 and NaCl. Drying, (MgSO4), evaporation and chromatographic purification affords 0.820 g of desired product.
(d) Moc-Gly-Ala-Leucinol: To a solution of 0.168 g (1.51 mmol) CaCl2 in 25 ml ethanol and 15 ml THF is added 0.250 g Moc-Gly-Ala-Leucine methyl ester.
This solution is cooled to -15°C and 0.114 g (3.02 mmol) NaBH4 is added in one portion. After stirring 2 h the reaction is quenched with 20 ml 1N
HCl, concentrated on rotovape and extracted with EtOAc (2x 50ml). The combined extracts
are washed with saturated NaHCO3 and NaCl, dried (MgSO4) and evaporated. Purification on silica provides 0.167 g of the pure product.
(e) Moc-Gly-Ala-LeuH- A solution is prepared by adding 0.418 g (0.989 mmol) Dess-Martin
periodinane to 5 ml CH2Cl2 followed by stirring for 10 minutes. Next 0.100 g (0.330 mmol) Moc-Gly-Ala-Leucinol
is added in one portion and the reaction stirred for 2 h and poured into a 25 ml solution
of saturated NaHCO3 containing 1.72 g (6.93 mmol) Na2S2O3. After stirring an additional 10 minutes the solution is extracted with EtOAc (3X,
50 ml), dried (MgSO4) and evaporated. Chromatography on silica affords 0.016 g of the desired product.
Synthesis Example 4:
Synthesis of N-(methylsulfonyl)-Phe-Gly-Ala-LeuH
[0037]
(a) N-Ms-Phe-Gly-OH: To a solution of 2.0 g (9.0 mmol) Phe-Gly-OH, which is dissolved
in 9 ml 1N NaOH and cooled to 0°C, is added simultaneously 0.766 ml ( 9.9 mmol) of
methane sulfonyl chloride and 9 ml 1N NaOH, in separate addition funnels. After addition
is complete the reaction is stirred 15 minutes at 0°C and 1 h at room temperature.
At this point the solution is cooled to 0°C, the pH adjusted to 9.5 and is washed
with EtOAc (1X, 50 ml). The aqueous phase (0°C) is then adjusted to pH = 2.5 (2N HCl)
and extracted with EtOAc (3X, 50 ml), dried (MgSO4), filtered, and the solvent removed to afford 2.0 g pure product
(b) N-Ms-Phe-Gly-Ala-Leucinol: A solution of is prepared by dissolving 0.500 g (1.67
mmol) N-Ms-Phe-Gly-OH in 15 ml THF, cooling to -15°C, and adding 0.366 ml (3.33 mmol)
NMM followed by 0.216 ml (1.67 mmol) isobutyl chloroformate. This solution is stirred
5 minutes and 0.374 g (1.67 mmol) Ala-Leucinol.HCl, in a mixture of 10 ml THF and
minimal DMF, are added. Stirring is continued at 0°C for 15 minutes and 2 h at room
temperature. The solution is quenched with 5 ml 1N HCl, extracted with EtOAc (3X,
50 ml), the combined extracts are washed with sat'd NaHCO3 and sat'd NaCl. The resulting organic phase is then dried (MgSO4), filtered, evaporated and chromatographed on silica to yield 0.260 g of the desired
material.
(c) N-Ms-Phe-Gly-Ala-LeuH: A solution is prepared by adding 0.337 g (0.798 mmol) Dess-Martin
periodinane to 5 ml CH2Cl2 and stirring for 10 minutes. To this solution 0.125 g (0.266 mmol) N-Ms-Phe-Gly-Ala-Leucinol
is added in one portion. The reaction is continued until TLC showed complete conversion
at which time the solution is poured into 25 ml sat'd NaHCO3 containing 1.8 g (5.586 mmol) Na2S2O3. After stirring for 10 minutes the mixture is extracted with EtOAc (3X, 50 ml). The
combined extracts are dried (MgSO4), evaporated, and chromatographed on silica to afford 0.048 g of the product.
Synthesis Example 5:
Synthesis of an aldehyde protease inhibitor
[0038] Moc-Leu-OH-L-Leucine (5.0 g, 38.2 mmol) is dissolved in 38 ml 1N NaOH and cooled
to 0°C. Methyl chloroformate (3.1 ml, 40.0 mmol) is added dropwise while in a separate
addition funnel 1N NaOH is added as to maintain pH at 9.0-9.5. After addition is complete
and the pH stabilized at 9.0-9.5 the solution is washed with 200 ml EtOAc. the aqueous
phase is then acidified to pH = 2. This mixture is extracted with EtOAc (2X 100 ml),
dried (MgSO
4), filtered, and the solvent removed to afford 7.15 g pure product.
[0039] Moc-Leu-Leucinol- To a solution of 3.5 g (18.52 mmol) Moc-Leu-OH in 100 ml THF, cooled
to -15°C, 2.04 ml (18.52 mmol) of N-methyl morpholine is added followed immediatedly
by 2.4 ml (18.52 mmol) isobutyl chloroformate. After stirring for 10 minutes 2.37
ml (18.52 mmol) of leucinol in 25 ml of THF is added and the reaction stirred 0.5
h at -15°C and 1 h at room temperature. The mixture is then diluted with 100 ml of
H
2O and the THF evaporated. The remaining aqueous phase is partitioned between EtOAc
and 1N HCl, the organic phase washed with NaHCO
3, dried (MgSO
4) and evaporated to afford 5.33 g pure product.
[0040] Moc-Leu-LeuH-A solution containing 4.4 g (10.41 mmol) Dens-Martin periodinane suspended
in 100 ml CH
2Cl
2 is prepared and stirred for 10 minutes. To this solution 1.0 g (3.47 mmol) Moc-Leu-Leucinol
is added and the solution stirred 2 h at room temperature followed by pouring into
100 ml of saturated NaHCO
3 containing 18 g (72.87 mmol) Na
2S
2O
3. This solution is stirred 10 minutes and then extracted with EtOAc (2X, 125ml), dried
(MgSO
4) and the solvent evaporated. Chromatography on silica affords 0.550 g of pure product.
Synthesis Example 6:
[0041] Additional peptide aldehydes are synthesized according to the following procedures.
Some of the intermediates are purchased from suppliers and in these instances it is
noted within the procedure. Dess-Martin periodinane is synthesized according to the
procedure of Martin, J.Org. Chem.,
1983, 48, 4155.
I. Z-Gly-Ala-Leu-OMe - To a solution of Z-Gly-Ala-OH (20.0 g, 0.071 M) and Leu-OMe.HCl
(12.9 g, 0.071 M) in 250 ml dichloromethane is added 21.9 ml (0.157 M) triethylamine
(TEA) dropwise over a period of 10 min. This addition is followed by the addition
of 11.9 ml (0.078 M) of diethylcyanophosphonate (DECP). The mixture is stirred overnight
and the solvent removed. The residue is dissolved in ethyl acetate and washed with
1N HCl, saturated NaHCO3, and brine. The solution is dried with MgSO4, filtered and the solvent removed. Recovered will be 29.0 g of product that is homogeneous
by TLC. 13C NMR (CDCl3) 15.93, 18.60, 21.77, 22.69, 24.72, 40.80, 44.20, 48.70, 50.87, 52.13, 65.28, 66.84,
127.92, 128.00, 128.41, 136.36, 156.76, 169.31, 172.58, 173.24.
II. Moc-Phe-Gly-Ala-Leu-OMe - Z-Gly-Ala-Leu-OMe (29.0 g, 0.071 M) is dissolved in
300 ml MeOH and 35 ml 4.0 M HCl in dioxane. To this solvent mixture is added 5.8 g
of 10% Pd/C portionwise. The slurry is degassed with an aspirator and H2 introduced via balloon. The slurry is maintained under a positive pressure of H2 and stirred overnight. The slurry is filtered through Celite and a sintered glass
funnel and washed thoroughly with MeOH. The solvent is removed and the residue is
triturated with ether. The slurry is filtered and the filter cake dried under vacuum.
Recovered 20.2 g of an off-white powder. The crude product and Moc-Phe-OH (15.3 g,
0.068 M) are dissolved in 500 ml CH2Cl2 and 29.9 ml TEA (0.143 M) added dropwise followed by the dropwise addition of 11.7
ml (0.072 M) of DECP. The mixture iss stirred overnight and the solvent is removed.
The residue is dissolved in EtOAc and washed with 1N HCl, saturated NaHCO3, and brine. The organic phase is dried (MgSO4), filtered and the solvent removed to afford 21.3 g product. 13C NMR (CDCl3) 16.66, 16.83, 20,01, 22.46, 23.41, 25.40, 40.11, 41.72, 43.75, 49.39, 51.37, 52.87,
56.42, 65.92, 77.39, 77.55, 77.81, 78.24, 127.42, 128.96, 129.19, 130.09, 137.41,
157.62, 169.00, 172.63, 173.24, 174.00.
III. Moc-Phe-Gly-Ala-Leucinol - Moc-Phe-Gly-Ala-Leu-OMe (21.3 g, 44.5 mmol) is dissolved
in a mixture of 400 ml EtOH and 250 ml THF. The solution is cooled to 0°C and 9.88
g (89.0 mmol) CaCl2 is added. In 5 min the slurry will be homogenized and 6.73 g (178.0 mmol) NaBH4 added portionwise over a period of 5 min. The solution is stirred at 0°C for 2 hours
and the reaction carefully quenched with 1N HCl. The EtOH and THF are removed under
vacuum and the remaining aqueous mixture extracted with 500 ml EtOAc. This organic
phase is washed with saturated NaHCO3, brine, and the organic phase dried with MgSO4. Filtration and removal of solvent affords 20.0 g of an off-white crystalline material.
Chromatography on silica (3.5% MeOH/CH2Cl2) gives 13.0 g pure product Rf= 0.3 (10% MeOH/CH2Cl2), 13C NMR (CDCl3) 17.50, 22.23, 23.12, 24.84, 37.22, 39.76, 43.96, 49.88, 50.93, 52.48, 58.22, 65.27,
98.46, 98.54, 127.04, 128.68, 129.10, 136.62, 157.85, 170.71, 173.85, 174.45
IV. Moc-Phe-Gly-Ala-Leu-H- 29.9 g (70.7 mmol) of Dess-Martin periodinane is suspended
in 500 ml CH2Cl2 and stirred for 10 min. Moc-Phe-Gly-Ala-Leucinol (10.6 g, 23.5 mmol) iss dissolved
in 100 ml CH2Cl2 and added at a moderate rate to the periodinane slurry. The mixture is stirred for
1h and poured into 150 ml NaHCO3 containing 123 g Na2S2O3. The mixture is allowed to stir for 15 min and extracted with EtOAc. The organic
phase is dried and filtered followed by removal of solvent. Chromatography (3.5% MeOH/CH2Cl2) on silica gives 5.1 g of pure white solid that is a mixture of the methoxy hemiacetal
and aldehyde. 13C NMR (CDCl3,CD3OD) 17.62, 17.94, 21.53, 21.71, 22.99, 23.30, 23.39, 24.54, 37.05, 37.70, 37.92, 38.24,
42.87, 49.83, 51.79, 52.14, 52.40, 56.75, 57.19, 98.40, 99.18, 127.00, 128.60, 129.06,
136.44, 157.27, 169.19, 169.67, 172.73, 173.40, 200.43.
V. Moc-Phe-OH - L-Phenylalanine (5.0 g, 30.2 mmol) is dissolved in 30 ml 1N NaOH and
cooled to 0°C. Methyl chloroformate (2.53 ml, 31.8 mmol) is added dropwise while in
a separate addition funnel 30 ml of 1N NaOH is added simultaneously. After addition
is complete, the solution is washed with 200 ml EtOAc and the aqueous phase acidified
to pH = 2. The mixture is extracted with EtOAc (2X 100 ml), dried (MgSO4), filtered, and the solvent removed to afford 6.0 g product 13C NMR (CDCl3) 37.75, 52.57, 54.64, 128.63, 129.35, 135.74, 156.77, 175.76.
VI. Mac-Phe-OH - To a solution of 1.00 g (2.34 mmol) of Phe-OBn.PTSA in Et2O at room temperature is added 0.36 ml (2.57 mmol) of TEA. This is followed by the
addition of 10 ml MeOH and then 0.14 ml (2.34 mmol) of methyl isocyanate in 4 ml Et2O is added dropwise. The reaction mixture is poured into 50 ml water and the phases
separate. The organic phase is dried with MgSO4, filtered and the solvent removed to give 0.66 g of product (96% yield). 13C NMR (CDCl3) 27.05, 38,47, 53.45, 54.64, 65.90, 127.43, 127.85, 128.48, 129.28, 130.27, 135.23,
136.22, 158.17, 173.08. To a solution of the crude product (2.11 mmol) in 25 ml MeOH
is added 0.120 g Pd/C and the slurry degassed. The slurry is stirred under a positive
pressure of H2 via balloon for 1.5 h. The slurry is filtered through Celite and the filter cake
washed with MeOH. The solvent is removed to afford 0.430 g product. 13C NMR 26.50, 37.92, 54.28, 126.69, 128.28, 129.28, 136.65, 159.36, 175.33.
VII. Mac-Phe-Gly-Ala-Leucinol - To a solution of 0.200 g Mac-Phe-OH (0.900 mmol) and
0.253 g Gly-Ala-Leu-OMe.HCl (0.818 mmol, generated by hydrogenation of I., above,
according to the procedure outlined for compound II.) in 15 ml DMF is added 0.250
ml TEA (1.80 mmol) followed by the addition of 0.147 ml DECP (0.900 mmol). The mixture
is stirred overnight and the solvent removed. The residue is redissolved in EtOAc
and washed successively with 0.3 N HCl, saturated NaHCO3, and brine. The solution is dried, filtered and the solvent removed to give 0.300
g product. The crude product (0.628 mmol) is dissolved in 17 ml EtOH and cooled to
0°C. To this solution is added 0.140 g CaCl2 (1.25 mmol) in 4 ml THF. To the resulting slurry is added 0.095 g NaBH4 in one portion. After 45 min. the solution is quenched with water and extracted with
EtOAc. The organic phase is dried with MgSO4, filtered and the solvent removed. Chromatography with 4% MeOH/CH2Cl2 gave 0.200 g pure product. 13C NMR (CD3OD) 16.84, 21.05, 22.60, 24.51, 25.66, 37.41, 39.73, 42.67, 49.65, 56.63, 64.33, 126.63,
128.32, 128.96, 137.12, 160.01, 170.45, 173.60, 175.03.
VIII. Mac-Phe-Gly-Ala-Leu-H- To a slurry of Dess-Martin periodinane (0.565 g, 1.33
mmol) in 15 ml CH2Cl2 is added a suspension of Mac-Phe-Gly-Ala-Leucinol (0.200 g, 0.445 mmol) in CH2Cl2 and the resulting slurry stirred for 0.5 h. The mixture is poured into saturated
NaHCO3 containing 2.32 g Na2S2O3 and the solution stirred for 10 min, followed by extraction with EtOAc. The organic
phase is dried with MgSO4, filtered and the solvent removed. The residue is chromatographed on silica to give
0.081 g product. 13C NMR (10% CD3OD in CDCl3) 17.18, 17.43, 21.35, 21.55, 23.26, 23.34, 24.40, 24.47, 26.36, 26.60, 37.25, 37.38,
38.60, 42.86, 42.97, 51.77, 51.93, 54.94, 56.75, 57.00, 98.7, 99.32, 126.87, 128.49,
128.91, 136.51, 159.53, 159.55, 169.93, 170.39, 173.63, 173.85, 174.70.
- Cbz =
- carbobenzyloxy
- Gly =
- glycine
- Ala =
- alanine
- Leu =
- leucine
- Phe =
- phenylalanine
- OMe =
- methyl ester
- TEA =
- triethylamine
- DECP =
- diethylcyanophosphonate
- TLC =
- thin layer chromatography
- MeOH =
- methanol
- Pd/C =
- palladium on activated carbon
- EtOH =
- ethanol
- THF =
- tetrahydrofuran
- Mac =
- methylaminocarbonyl
- Moc =
- methoxycarbonyl
- Etoc =
- ethoxycarbonyl
- Ms =
- methanesulfonyl
[0042] Proteolytic Enzyme - Another essential ingredient in the present liquid detergent compositions is active
proteolytic enzyme. Mixtures of proteolytic enzyme are also included. The proteolytic
enzyme can be of animal, vegetable or microorganism (preferred) origin. The proteases
for use in the detergent compositions herein include (but are not limited to) trypsin,
subtilisin, chymotrypsin and elastase-type proteases. Preferred for use herein are
subtilisin-type proteolytic enzymes. Particularly preferred is bacterial serine proteolytic
enzyme obtained from
Bacillus subtilis and/or
Bacillus licheniformis. Protease enzymes are usually present in such liquid detergent compositions at levels
sufficient to provide from 0.005 to 0.1 Anson units (AU) of activity per gram of composition.
[0043] Suitable proteolytic enzymes include Novo Industri A/S Alcalase® (preferred), Esperase®,
Savinase® (Copenhagen, Denmark), Gist-brocades' Maxatase®, Maxacal® and Maxapem 15®
(protein engineered Maxacal®) (Delft, Netherlands), and subtilisin BPN and BPN'(preferred),
which are commercially available. Preferred proteolytic enzymes are also modified
bacterial serine proteases, such as those made by Genencor International, Inc.(San
Francisco, California) which are described in European Patent 251,446, filed April
28, 1987 (particularly pages 17, 24 and 98), and which is called herein "Protease
B", and U.S. Patent 5,030,378, Venegas, issued July 9, 1991, which refers to a modified
bacterial serine proteolytic enzyme (Genencor International) which is called "Protease
A" herein (same as BPN'). In particular see columns 2 and 3 of U.S. Patent 5,030,378
for a complete description, including amino sequence, of Protease A and its variants.
Preferred proteolytic enzymes, then, are selected from the group consisting of Alcalase
® (Novo Industri A/S), BPN', Protease A and Protease B (Genencor), and mixtures thereof.
Protease B is most preferred.
[0044] Another preferred protease, referred to as "Protease D" is a carbonyl hydrolase variant
having an amino acid sequence not found in nature, which is derived from a precursor
carbonyl hydrolase by substituting a different amino acid for a plurality of amino
acid residues at a position in said carbonyl hydrolase equivalent to position +76,
preferably also in combination with one or more amino acid residue positions equivalent
to those selected from the group consisting of +99, +101, +103, +104, +107, +123,
+27, +105, +109, +126, +128, +135, +156, +166, +195, +197, +204, +206, +210, +216,
+217, +218, +222, +260, +265, and/or +274 according to the numbering of
Bacillus amyloliquefaciens subtilisin, as described in WO 95/10615 published April 20, 1995 by Genencor International.
[0045] Useful proteases are also described in PCT publications: WO 95/30010 published Novenber
9, 1995 by The Procter & Gamble Company; WO 95/30011 published Novenber 9, 1995 by
The Procter & Gamble Company; WO 95/29979 published Novenber 9, 1995 by The Procter
& Gamble Company.
[0046] Calcium - Any water-soluble calcium salt can be used as a source of calcium ions, including
calcium acetate, calcium formate, calcium xylene sulfonate, and calcium propionate.
Divalent ions, such as zinc and magnesium ions, can replace the calcium ion in part.
Thus in the liquid detergent compositions herein, the source of calcium ions can be
partially substituted with a source of another divalent ion.
[0047] The calcium useful herein is enzyme-accessible. Therefore, the claimed compositions
are substantially free of sequestrants, for example, polyacids capable of forming
calcium complexes which are soluble in the composition. However, minor amounts of
sequestrants such as polyacids or mixtures of polyacids can be used. The enzyme-accessible
calcium is defined as the amount of calcium-ions effectively available to the enzyme
component. From a practical standpoint the enzyme-accessible calcium is therefore
the soluble calcium in the composition in the absence of any storage sequestrants,
e.g., having an equilibrium constant of complexation with calcium equal to or greater
than 1.5 at 20°C.
[0048] Boric Acid - The compositions herein optionally contain from about 0.25% to about 10%, preferably
from about 0.5% to about 5%, more preferably from about 0.75% to about 3%, by weight
of boric acid or a compound capable of forming boric acid in the composition (calculated
on the basis of the boric acid). Boric acid is preferred, although other compounds
such as boric oxide, borax and other alkali metal borates (e.g., sodium ortho-, meta-,
pyroborate, an sodium pentaborate) are suitable. Substituted boric acids (e.g., phenylboronic
acid, butane boronic acid, and p-bromo phenylboronic acid) can also be used in place
of boric acid.
[0049] The compositions of the present invention can also contain polyols, especially diols,
containing only carbon, hydrogen and oxygen atoms. They preferably contain from about
2 to about 6 hydroxy groups. Examples include propylene glycol (especially 1,2 propanediol,
which is preferred), ethylene glycol, glycerol, sorbitol, mannitol, glucose, and mixtures
thereof. The polyol generally represents from about 1% to about 15%, preferably from
about 1.5% to about 10%, more preferably from about 2% to about 7%, by weight of the
composition.
[0050] Detersive Surfactant - An effective amount, from 1 to 95, preferably 8 to 70, weight %, of detersive surfactant
is yet another essential ingredient in the present invention. The detersive surfactant
can be selected from the group consisting of anionics, nonionics, cationics, ampholytics,
zwitterionics, and mixtures thereof. By selecting the type and amount of detersive
surfactant, along with other adjunct ingredients disclosed herein, the present detergent
compositions can be formulated to be used in the context of laundry cleaning or in
other different cleaning applications, particularly including dishwashing. The particular
surfactants used can therefore vary widely depending upon the particular end-use envisioned.
[0051] The benefits of the present invention are especially pronounced in compositions containing
ingredients that are harsh to enzymes such as certain detergency builders and surfactants.
These include (but are not limited to) anionic surfactants such as alkyl ether sulfate
linear alkyl benzene sulfonate, alkyl sulfate. Suitable surfactants are described
below.
[0052] Anionic Surfactants - One type of anionic surfactant which can be utilized encompasses alkyl ester sulfonates.
These are desirable because they can be made with renewable, non-petroleum resources.
Preparation of the alkyl ester sulfonate surfactant component can be effected according
to known methods disclosed in the technical literature. For instance, linear esters
of C
8-C
20 carboxylic acids can be sulfonated with gaseous SO
3 according to "The Journal of the American Oil Chemists Society," 52 (1975), pp. 323-329.
Suitable starting materials would include natural fatty substances as derived from
tallow, palm, and coconut oils, etc.
[0053] The preferred alkyl ester sulfonate surfactant, especially for laundry applications,
comprises alkyl ester sulfonate surfactants of the structural formula:

wherein R
3 is a C
8-C
20 hydrocarbyl, preferably an alkyl, or combination thereof, R
4 is a C
1-C
6 hydrocarbyl, preferably an alkyl, or combination thereof, and M is a soluble salt-forming
cation. Suitable salts include metal salts such as sodium, potassium, and lithium
salts, and substituted or unsubstituted ammonium salts, such as methyl-, dimethyl,
-trimethyl, and quaternary ammonium cations, e.g. tetramethyl-ammonium and dimethyl
piperdinium, and cations derived from alkanolamines, e.g. monoethanol-amine, diethanolamine,
and triethanolamine. Preferably, R
3 is C
10-C
16 alkyl, and R
4 is methyl, ethyl or isopropyl. Especially preferred are the methyl ester sulfonates
wherein R
3 is C
14-C
16 alkyl.
[0054] Alkyl sulfate surfactants are another type of anionic surfactant of importance for
use herein. In addition to providing excellent overall cleaning ability when used
in combination with polyhydroxy fatty acid amides (see below), including good grease/oil
cleaning over a wide range of temperatures, wash concentrations, and wash times, dissolution
of alkyl sulfates can be obtained, as well as improved formulability in liquid detergent
formulations are water soluble salts or acids of the formula ROSO
3M wherein R preferably is a C
10-C
24 hydrocarbyl, preferably an alkyl or hydroxyalkyl having a C
10-C
20 alkyl component, more preferably a C
12-C
18 alkyl or hydroxyalkyl, and M is H or a cation, e.g., an alkali metal cation (e.g.,
sodium, potassium, lithium), substituted or unsubstituted ammonium cations such as
methyl-, dimethyl-, and trimethyl ammonium and quaternary ammonium cations, e.g.,
tetramethyl-ammonium and dimethyl piperdinium, and cations derived from alkanolamines
such as ethanolamine, diethanolamine, triethanolamine, and mixtures thereof, and the
like. Typically, alkyl chains of C
12-16 are preferred for lower wash temperatures (e.g., below about 50°C) and C
16-18 alkyl chains are preferred for higher wash temperatures (e.g., above about 50°C).
[0055] Alkyl alkoxylated sulfate surfactants are another category of useful anionic surfactant.
These surfactants are water soluble salts or acids typically of the formula RO(A)
mSO
3M wherein R is an unsubstituted C
10-C
24 alkyl or hydroxyalkyl group having a C
10-C
24 alkyl component, preferably a C
12-C
20 alkyl or hydroxyalkyl, more preferably C
12-C
18 alkyl or hydroxyalkyl, A is an ethoxy or propoxy unit, m is greater than zero, typically
between about 0.5 and about 6, more preferably between about 0.5 and about 3, and
M is H or a cation which can be, for example, a metal cation (e.g., sodium, potassium,
lithium, calcium, magnesium, etc.), ammonium or substituted-ammonium cation. Alkyl
ethoxylated sulfates as well as alkyl propoxylated sulfates are contemplated herein.
Specific examples of substituted ammonium cations include methyl-, dimethyl-, trimethyl-ammonium
and quaternary ammonium cations, such as tetramethyl-ammonium, dimethyl piperidinium
and cations derived from alkanolamines, e.g. monoethanolamine, diethanolamine, and
triethanolamine, and mixtures thereof. Exemplary surfactants are C
12-C
18 alkyl polyethoxylate (1.0) sulfate, C
12-C
18 alkyl polyethoxylate (2.25) sulfate, C
12-C
18 alkyl polyethoxylate (3.0) sulfate, and C
12-C
18 alkyl polyethoxylate (4.0) sulfate wherein M is conveniently selected from sodium
and potassium.
[0056] Other Anionic Surfactants - Other anionic surfactants useful for detersive purposes can also be included in the
compositions hereof. These can include salts (including, for example, sodium, potassium,
ammonium, and substituted ammonium salts such as mono-, di- and triethanolamine salts)
of soap, C
9-C
20 linear alkylbenzenesulphonates, C
8-C
22 primary or secondary alkanesulphonates, C
8-C
24 olefinsulphonates, sulphonated polycarboxylic acids prepared by sulphonation of the
pyrolyzed product of alkaline earth metal citrates, e.g., as described in British
patent specification No. 1,082,179, alkyl glycerol sulfonates, fatty acyl glycerol
sulfonates, fatty oleyl glycerol sulfates, alkyl phenol ethylene oxide ether sulfates,
paraffin sulfonates, alkyl phosphates, isothionates such as the acyl isothionates,
N-acyl taurates, fatty acid amides of methyl tauride, alkyl succinamates and sulfosuccinates,
monoesters of sulfosuccinate (especially saturated and unsaturated C
12-C
18 monoesters) diesters of sulfosuccinate (especially saturated and unsaturated C
6-C
14 diesters), N-acyl sarcosinates, sulfates of alkylpolysaccharides such as the sulfates
of alkylpolyglucoside (the nonionic nonsulfated compounds being described below),
branched primary alkyl sulfates, alkyl polyethoxy carboxylates such as those of the
formula RO(CH
2CH
2O)
kCH
2COO-M
+ wherein R is a C
8-C
22 alkyl, k is an integer from 0 to 10, and M is a soluble salt-forming cation, and
fatty acids esterified with isethionic acid and neutralized with sodium hydroxide.
Resin acids and hydrogenated resin acids are also suitable, such as rosin, hydrogenated
rosin, and resin acids and hydrogenated resin acids present in or derived from tall
oil. Further examples are given in "Surface Active Agents and Detergents" (Vol. I
and II by Schwartz, Perry and Berch). A variety of such surfactants are also generally
disclosed in U.S. Patent 3,929,678, issued December 30, 1975 to Laughlin, et al. at
Column 23, line 58 through Column 29, line 23.
[0057] Nonionic Detergent Surfactants - Suitable nonionic detergent surfactants are generally disclosed in U.S. Patent 3,929,678,
Laughlin et al., issued December 30, 1975, at column 13, line 14 through column 16,
line 6. Exemplary, non-limiting classes of useful nonionic surfactants are listed
below.
[0058] The polyethylene, polypropylene, and polybutylene oxide condensates of alkyl phenols.
In general, the polyethylene oxide condensates are preferred. These compounds include
the condensation products of alkyl phenols having an alkyl group containing from about
6 to about 12 carbon atoms in either a straight chain or branched chain configuration
with the alkylene oxide. In a preferred embodiment, the ethylene oxide is present
in an amount equal to from about 5 to about 25 moles of ethylene oxide per mole of
alkyl phenol. Commercially available nonionic surfactants of this type include Igepal®
CO-630, marketed by the GAF Corporation; and Triton® X-45, X-114, X-100, and X-102,
all marketed by the Rohm & Haas Company. These compounds are commonly referred to
as alkyl phenol alkoxylates, (e.g., alkyl phenol ethoxylates).
[0059] The condensation products of aliphatic alcohols with from about 1 to about 25 moles
of ethylene oxide. The alkyl chain of the aliphatic alcohol can either be straight
or branched, primary or secondary, and generally contains from about 8 to about 22
carbon atoms. Particularly preferred are the condensation products of alcohols having
an alkyl group containing from about 10 to about 20 carbon atoms with from about 2
to about 18 moles of ethylene oxide per mole of alcohol. Examples of commercially
available nonionic surfactants of this type include Tergitol® 15-S-9 (the condensation
product of C
11-C
15 linear secondary alcohol with 9 moles ethylene oxide), Tergitol® 24-L-6 NMW (the
condensation product of C
12-C
14 primary alcohol with 6 moles ethylene oxide with a narrow molecular weight distribution),
both marketed by Union Carbide Corporation; Neodol® 45-9 (the condensation product
of C
14-C
15 linear alcohol with 9 moles of ethylene oxide), Neodol® 23-6.5 (the condensation
product of C
12-C
13 linear alcohol with 6.5 moles of ethylene oxide), Neodol® 45-7 (the condensation
product of C
14-C
15 linear alcohol with 7 moles of ethylene oxide), Neodol® 45-4 (the condensation product
of C
14-C
15 linear alcohol with 4 moles of ethylene oxide), marketed by Shell Chemical Company,
and Kyro® EOB (the condensation product of C
13-C
15 alcohol with 9 moles ethylene oxide), marketed by The Procter & Gamble Company. This
category of nonionic surfactant is referred to generally as "alkyl ethoxylates."
[0060] The condensation products of ethylene oxide with a hydrophobic base formed by the
condensation of propylene oxide with propylene glycol. The hydrophobic portion of
these compounds preferably has a molecular weight of from about 1500 to about 1800
and exhibits water insolubility. The addition of polyoxyethylene moieties to this
hydrophobic portion tends to increase the water solubility of the molecule as a whole,
and the liquid character of the product is retained up to the point where the polyoxyethylene
content is about 50% of the total weight of the condensation product, which corresponds
to condensation with up to about 40 moles of ethylene oxide. Examples of compounds
of this type include certain of the commercially-available Pluronic® surfactants,
marketed by BASF.
[0061] The condensation products of ethylene oxide with the product resulting from the reaction
of propylene oxide and ethylenediamine. The hydrophobic moiety of these products consists
of the reaction product of ethylenediamine and excess propylene oxide, and generally
has a molecular weight of from about 2500 to about 3000. This hydrophobic moiety is
condensed with ethylene oxide to the extent that the condensation product contains
from about 40% to about 80% by weight of polyoxyethylene and has a molecular weight
of from about 5,000 to about 11,000. Examples of this type of nonionic surfactant
include certain of the commercially available Tetronic® compounds, marketed by BASF.
[0062] Semi-polar nonionic surfactants are a special category of nonionic surfactants which
include water-soluble amine oxides containing one alkyl moiety of from about 10 to
about 18 carbon atoms and 2 moieties selected from the group consisting of alkyl groups
and hydroxyalkyl groups containing from about 1 to about 3 carbon atoms; water-soluble
phosphine oxides containing one alkyl moiety of from about 10 to about 18 carbon atoms
and 2 moieties selected from the group consisting of alkyl groups and hydroxyalkyl
groups containing from about 1 to about 3 carbon atoms; and water-soluble sulfoxides
containing one alkyl moiety of from about 10 to about 18 carbon atoms and a moiety
selected from the group consisting of alkyl and hydroxyalkyl moieties of from about
1 to about 3 carbon atoms.
[0063] Semi-polar nonionic detergent surfactants include the amine oxide surfactants having
the formula

wherein R
3 is an alkyl, hydroxyalkyl, or alkyl phenyl group or mixtures thereof containing from
about 8 to about 22 carbon atoms; R
4 is an alkylene or hydroxyalkylene group containing from about 2 to about 3 carbon
atoms or mixtures thereof; x is from 0 to about 3; and each R
5 is an alkyl or hydroxyalkyl group containing from about 1 to about 3 carbon atoms
or a polyethylene oxide group containing from about 1 to about 3 ethylene oxide groups.
The R
5 groups can be attached to each other, e.g., through an oxygen or nitrogen atom, to
form a ring structure.
[0064] These amine oxide surfactants in particular include C
10-C
18 alkyl dimethyl amine oxides and C
8-C
12 alkoxy ethyl dihydroxy ethyl amine oxides.
[0065] Alkylpolysaccharides disclosed in U.S. Patent 4,565,647, Llenado, issued January
21, 1986, having a hydrophobic group containing from about 6 to about 30 carbon atoms,
preferably from about 10 to about 16 carbon atoms and a polysaccharide, e.g., a polyglycoside,
hydrophilic group containing from about 1.3 to about 10, preferably from about 1.3
to about 3, most preferably from about 1.3 to about 2.7 saccharide units. Any reducing
saccharide containing 5 or 6 carbon atoms can be used, e.g., glucose, galactose and
galactosyl moieties can be substituted for the glucosyl moieties. (Optionally the
hydrophobic group is attached at the 2-, 3-, 4-, etc. positions thus giving a glucose
or galactose as opposed to a glucoside or galactoside.) The intersaccharide bonds
can be, e.g., between the one position of the additional saccharide units and the
2-, 3-, 4-, and/or 6- positions on the preceding saccharide units.
[0066] Optionally, and less desirably, there can be a polyalkylene-oxide chain joining the
hydrophobic moiety and the polysaccharide moiety. The preferred alkyleneoxide is ethylene
oxide. Typical hydrophobic groups include alkyl groups, either saturated or unsaturated,
branched or unbranched containing from about 8 to about 18, preferably from about
10 to about 16, carbon atoms. Preferably, the alkyl group is a straight chain saturated
alkyl group. The alkyl group can contain up to about 3 hydroxy groups and/or the polyalkyleneoxide
chain can contain up to about 10, preferably less than 5, alkyleneoxide moieties.
Suitable alkyl polysaccharides are octyl, nonyl, decyl, undecyldodecyl, tridecyl,
tetradecyl, pentadecyl, hexadecyl, heptadecyl, and octadecyl, di-, tri-, tetra-, penta-,
and hexaglucosides, galactosides, lactosides, glucoses, fructosides, fructoses and/or
galactoses. Suitable mixtures include coconut alkyl, di-, tri-, tetra-, and pentaglucosides
and tallow alkyl tetra-, penta-, and hexa-glucosides.
[0067] The preferred alkylpolyglycosides have the formula
R
2O(C
nH
2nO)
t(glycosyl)
x
wherein R
2 is selected from the group consisting of alkyl, alkyl-phenyl, hydroxyalkyl, hydroxyalkylphenyl,
and mixtures thereof in which the alkyl groups contain from about 10 to about 18,
preferably from about 12 to about 14, carbon atoms; n is 2 or 3, preferably 2; t is
from 0 to about 10, preferably 0; and x is from about 1.3 to about 10, preferably
from about 1.3 to about 3, most preferably from about 1.3 to about 2.7. The glycosyl
is preferably derived from glucose. To prepare these compounds, the alcohol or alkylpolyethoxy
alcohol is formed first and then reacted with glucose, or a source of glucose, to
form the glucoside (attachment at the 1-position). The additional glycosyl units can
then be attached between their 1-position and the preceding glycosyl units 2-, 3-,
4- and/or 6-position, preferably predominantly the 2-position.
[0068] Fatty acid amide surfactants having the formula:

wherein R
6 is an alkyl group containing from about 7 to about 21 (preferably from about 9 to
about 17) carbon atoms and each R
7 is selected from the group consisting of hydrogen, C
1-C
4 alkyl, C
1-C
4 hydroxyalkyl, and -(C
2H
4O)
xH where x varies from about 1 to about 3.
[0069] Preferred amides are C
8-C
20 ammonia amides, monoethanolamides, diethanolamides, and isopropanolamides.
[0070] Cationic Surfactants - Cationic detersive surfactants can also be included in detergent compositions of
the present invention. Cationic surfactants include the ammonium surfactants such
as alkyldimethylammonium halogenides, and those surfactants having the formula:
[R
2(OR
3)
y][R
4(OR
3)
y]
2R
5N
+X
-
wherein R
2 is an alkyl or alkyl benzyl group having from about 8 to about 18 carbon atoms in
the alkyl chain, each R
3 is selected from the group consisting of -CH
2CH
2-, -CH
2CH(CH
3)-, -CH
2CH(CH
2OH)-, -CH
2CH
2CH
2-, and mixtures thereof; each R
4 is selected from the group consisting of C
1-C
4 alkyl, C
1-C
4 hydroxyalkyl, benzyl, ring structures formed by joining the two R
4 groups, -CH
2CHOHCHOHCOR
6CHOH-CH
2OH wherein R
6 is any hexose or hexose polymer having a molecular weight less than about 1000, and
hydrogen when y is not O; R
5 is the same as R
4 or is an alkyl chain wherein the total number of carbon atoms of R
2 plus R
5 is not more than about 18; each y is from 0 to about 10 and the sum of the y values
is from 0 to about 15; and X is any compatible anion.
[0071] Other cationic surfactants useful herein are also described in U.S. Patent 4,228,044,
Cambre, issued October 14,1980,
[0072] Other Surfactants - Ampholytic surfactants can be incorporated into the detergent compositions hereof.
These surfactants can be broadly described as aliphatic derivatives of secondary or
tertiary amines, or aliphatic derivatives of heterocyclic secondary and tertiary amines
in which the aliphatic radical can be straight chain or branched. One of the aliphatic
substituents contains at least about 8 carbon atoms, typically from about 8 to about
18 carbon atoms, and at least one contains an anionic water-solubilizing group, e.g.,
carboxy, sulfonate, sulfate. See U.S. Patent No. 3,929,678 to Laughlin et al., issued
December 30, 1975 at column 19, lines 18-35 for examples of ampholytic surfactants.
[0073] Zwitterionic surfactants can also be incorporated into the detergent compositions
hereof. These surfactants can be broadly described as derivatives of secondary and
tertiary amines, derivatives of heterocyclic secondary and tertiary amines, or derivatives
of quaternary ammonium, quaternary phosphonium or tertiary sulfonium compounds. See
U.S. Patent No. 3,929,678 to Laughlin et al., issued December 30, 1975 at column 19,
line 38 through column 22, line 48 for examples of zwitterionic surfactants. Ampholytic
and zwitterionic surfactants are generally used in combination with one or more anionic
and/or nonionic surfactants.
[0074] Polyhydroxy Fatty Acid Amide Surfactant - The liquid detergent compositions hereof may also contain an enzyme-enhancing amount
of polyhydroxy fatty acid amide surfactant. By "enzyme-enhancing" is meant that the
formulator of the composition can select an amount of polyhydroxy fatty acid amide
to be incorporated into the compositions that will improve enzyme cleaning performance
of the detergent composition. In general, for conventional levels of enzyme, the incorporation
of about 1%, by weight, polyhydroxy fatty acid amide will enhance enzyme performance.
[0075] The detergent compositions herein will typically comprise about 1% weight basis,
polyhydroxy fatty acid amide surfactant, preferably from about 3% to about 30%, of
the polyhydroxy fatty acid amide. The polyhydroxy fatty acid amide surfactant component
comprises compounds of the structural formula:

wherein: R
1 is H, C
1-C
4 hydrocarbyl, 2-hydroxy ethyl, 2-hydroxy propyl, or a mixture thereof, preferably
C
1-C
4 alkyl, more preferably C
1 or C
2 alkyl, most preferably C
1 alkyl (i.e., methyl); and R
2 is a C
5-C
31 hydrocarbyl, preferably straight chain C
7-C
19 alkyl or alkenyl, more preferably straight chain C
9-C
17 alkyl or alkenyl, most preferably straight chain C
11-C
15 alkyl or alkenyl, or mixtures thereof; and Z is a polyhydroxyhydrocarbyl having a
linear hydrocarbyl chain with at least 3 hydroxyls directly connected to the chain,
or an alkoxylated derivative (preferably ethoxylated or propoxylated) thereof. Z preferably
will be derived from a reducing sugar in a reductive amination reaction; more preferably
Z will be a glycityl. Suitable reducing sugars include glucose, fructose, maltose,
lactose, galactose, mannose, and xylose. As raw materials, high dextrose corn syrup,
high fructose corn syrup, and high maltose corn syrup can be utilized as well as the
individual sugars listed above. These corn syrups may yield a mix of sugar components
for Z. It should be understood that it is by no means intended to exclude other suitable
raw materials. Z preferably will be selected from the group consisting of -CH
2-(CHOH)
n-CH
2OH, -CH(CH
2OH)-(CHOH)
n-1-CH
2OH, -CH
2-(CHOH)
2(CHOR')(CHOH)-CH
2OH, and alkoxylated derivatives thereof, where n is an integer from 3 to 5, inclusive,
and R' is H or a cyclic or aliphatic monosaccharide. Most preferred are glycityls
wherein n is 4, particularly -CH
2-(CHOH)
4-CH
2OH.
[0076] R' can be, for example, N-methyl, N-ethyl, N-propyl, N-isopropyl, N-butyl, N-2-hydroxy
ethyl, or N-2-hydroxy propyl.
[0077] R
2-CO-N< can be, for example, cocamide, stearamide, oleamide, lauramide, myristamide,
capricamide, palmitamide, tallowamide, etc.
[0078] Z can be 1-deoxyglucityl, 2-deoxyfructityl, 1-deoxymaltityl, 1-deoxylactityl, 1-deoxygalactityl,
1-deoxymannityl, 1-deoxymaltotriotityl, etc.
[0079] Methods for making polyhydroxy fatty acid amides are known in the art. In general,
they can be made by reacting an alkyl amine with a reducing sugar in a reductive amination
reaction to form a corresponding N-alkyl polyhydroxyamine, and then reacting the N-alkyl
polyhydroxyamine with a fatty aliphatic ester or triglyceride in a condensation/amidation
step to form the N-alkyl, N-polyhydroxy fatty acid amide product. Processes for making
compositions containing polyhydroxy fatty acid amides are disclosed, for example,
in G.B. Patent Specification 809,060, published February 18, 1959, by Thomas Hedley
& Co., Ltd., U.S. Patent 2,965,576, issued December 20, 1960 to E. R. Wilson, and
U.S. Patent 2,703,798, Anthony M. Schwartz, issued March 8, 1955, and U.S. Patent
1,985,424, issued December 25, 1934 to Piggott.
[0080] Second Enzyme - Preferred compositions herein further comprise a performance-enhancing amount of
a detergent-compatible second enzyme. By "detergent-compatible" is meant compatibility
with the other ingredients of a liquid detergent composition, such as detersive surfactant
and detergency builder. These second enzymes are preferably selected from the group
consisting of lipase, amylase, cellulase, and mixtures thereof. The term "second enzyme"
excludes the proteolytic enzymes discussed above, so each composition which has a
second enzyme contains at least two kinds of enzyme, including at least one proteolytic
enzyme. The amount of second enzyme used in the composition varies according to the
type of enzyme. In general, from about 0.0001 to 0.3, more preferably 0.001 to 0.1,
weight % of these second enzymes are preferably used. Mixtures of the same class of
enzymes (e.g. lipase) or two or more classes (e.g. cellulase and lipase) may be used.
Purified or non-purified forms of the enzyme may be used.
[0081] Any lipolytic enzyme suitable for use in a liquid detergent composition can be used
in these compositions. Suitable lipase enzymes for use herein include those of bacterial
and fungal origin.
[0082] Suitable bacterial lipases include those produced by microorganisms of the
Pseudomonas groups, such as
Pseudomonas stutzeri ATCC 19.154, as disclosed in British Patent 1,372,034. Suitable lipases include those
which show a positive immunological cross-reaction with the antibody of the lipase
produced by the microorganism
Pseudomonas fluorescens IAM 1057. This lipase and a method for its purification have been described in Japanese
Patent Application 53-20487, laid open on February 24, 1978. This lipase is available
from Amano Pharmaceutical Co. Ltd., Nagoya, Japan, under the trade name Lipase P "Amano,"
hereinafter referred to as "Amano-P." Such lipases should show a positive immunological
cross-reaction with the Amano-P antibody, using the standard and well-known immunodiffusion
procedure according to Ouchterlony (Acta. Med. Scan., 133, pages 76-79 (1950)). These
lipases, and a method for their immunological cross-reaction with Amano-P, are also
described in U.S. Patent 4,707,291, Thom et al., issued November 17, 1987. Typical
examples thereof are the Amano-P lipase, the lipase ex
Pseudomonas fragi FERM P 1339 (available under the trade name Amano-B), lipase ex
Pseudomonas nitroreducens var.
lipolyticum FERM P 1338 (available under the trade name Amano-CES), lipases ex
Chromobacter viscosum, e.g.
Chromobacter viscosum var.
lipolyticum NRRLB 3673, commercially available from Toyo Jozo Co., Tagata, Japan; and further
Chromobacter viscosum lipases from U.S. Biochemical Corp., U.S.A. and Disoynth Co., The Netherlands, and
lipases ex
Pseudomonas gladioli.
[0083] Suitable fungal lipases include those producible by
Humicola lanuginosa and
Thermomyces lanuginosus. Most preferred is lipase obtained by cloning the gene from
Humicola lanuginosa and expressing the gene in
Aspergillus oryzae as described in European Patent Application 0 258 068 (Novo Industri A/S), commercially
available from Novo Nordisk A/S under the trade name Lipolase®.
[0084] From about 10 to 18,000, preferably about 60 to 6,000, lipase units per gram (LU/g)
of lipase can be used in these compositions. A lipase unit is that amount of lipase
which produces 1 mmol of titratable fatty acid per minute in a pH stat, where pH is
9.0, temperature is 30°C, substrate is an emulsion of 3.3wt % of olive oil and 3.3%
gum arabic, in the presence of 13 mmol/l Ca
++ and 20 mmol/l NaCl in 5 mmol/l Tris-buffer.
[0085] Any cellulase suitable for use in a liquid detergent composition can be used in these
compositions. Suitable cellulase enzymes for use herein include those from bacterial
and fungal origins. Preferably, they will have a pH optimum of between 5 and 9.5.
From about 0.0001 to 0.1 weight % cellulase can be used.
[0086] Suitable cellulases are disclosed in U.S. Patent 4,435,307, Barbesgaard et al., issued
March 6, 1984, incorporated herein by reference, which discloses fungal cellulase
produced from
Humicola insolens. Suitable cellulases are also disclosed in GB-A-2.075.028, GB-A-2.095.275 and DE-OS-2.247.832.
[0087] Examples of such cellulases are cellulases produced by a strain of
Humicola insolens (Humicola grisea var.
thermoidea), particularly the Humicola strain DSM 1800, and cellulases produced by a fungus of
Bacillus N or a cellulase 212-producing fungus belonging to the genus
Aeromonas, and cellulase extracted from the hepatopancreas of a marine mollusc (Dolabella Auricula
Solander).
[0088] Any amylase suitable for use in a liquid detergent composition can be used in these
compositions. Amylases include, for example, amylases obtained from a special strain
of
B.licheniformis, described in more detail in British Patent Specification No. 1,296,839 (Novo). Amylolytic
proteins include, for example, Rapidase
R, International Bio-Synthetics, Inc. and Termamyl
R Novo Industries.
[0089] From about 0.0001% to 0.55, preferably 0.0005 to 0.1, wt. % amylase can be used.
[0090] Optional Ingredients - Detergent builders can optionally be included in the compositions herein, especially
for laundry compositions. Inorganic as well as organic builders can be used. When
present, the compositions will typically comprise at least about 1% builder and can
be either an inorganic or organic builder. Liquid laundry formulations preferably
comprise from about 3% to 30%, more preferably about 5 to 20%, by weight, of detergent
builder.
[0091] Inorganic detergent builders include, but are not limited to, the alkali metal, ammonium
and alkanolammonium salts of polyphosphates (exemplified by the tripolyphosphates,
pyrophosphates, and glassy polymeric meta-phosphates), phosphonates, phytic acid,
silicates, carbonates (including bicarbonates and sesquicarbonates), sulphates, and
aluminosilicates. Borate builders, as well as builders containing borate-forming materials
that can produce borate under detergent storage or wash conditions (hereinafter, collectively
"borate builders"), can also be used. Preferably, non-borate builders are used in
the compositions of the invention intended for use at wash conditions less than about
50°C, especially less than about 40°C.
[0092] Examples of silicate builders are the alkali metal silicates, particularly those
having a SiO
2:Na
2O ratio in the range 1.6:1 to 3.2:1 and layered silicates, such as the layered sodium
silicates described in U.S. Patent 4,664,839, issued May 12, 1987 to H. P. Rieck.
However, other silicates may also be useful such as for example magnesium silicate,
which can serve as a crispening agent in granular formulations, as a stabilizing agent
for oxygen bleaches, and as a component of suds control systems.
[0093] Examples of carbonate builders are the alkaline earth and alkali metal carbonates,
including sodium carbonate and sesquicarbonate and mixtures thereof with ultra-fine
calcium carbonate as disclosed in German Patent Application No. 2,321,001 published
on November 15, 1973.
[0094] Aluminosilicate builders are useful in the present invention. Aluminosilicate builders
are of great importance in most currently marketed heavy duty granular detergent compositions,
and can also be a significant builder ingredient in liquid detergent formulations.
Aluminosilicate builders include those having the empirical formula:
M
z(zAlO
2·ySiO
2)
wherein M is sodium, potassium, ammonium or substituted ammonium, z is from about
0.5 to about 2; and y is 1; this material having a magnesium ion exchange capacity
of at least about 50 milligram equivalents of CaCO
3 hardness per gram of anhydrous aluminosilicate. Preferred alumino-silicates are zeolite
builders which have the formula:
Na
z[(AlO
2)
z(SiO
2)
y].xH
2O
wherein z and y are integers of at least 6, the molar ratio of z to y is in the range
from 1.0 to about 0.5, and x is an integer from about 15 to about 264.
[0095] Useful aluminosilicate ion exchange materials are commercially available. These aluminosilicates
can be crystalline or amorphous in structure and can be naturally-occurring aluminosilicates
or synthetically derived. A method for producing aluminosilicate ion exchange materials
is disclosed in U.S. Patent 3,985,669, Krummel, et al., issued October 12, 1976. Preferred
synthetic crystalline aluminosilicate ion exchange materials useful herein are available
under the designations Zeolite A, Zeolite P (B), and Zeolite X. In an especially preferred
embodiment, the crystalline aluminosilicate ion exchange material has the formula:
Na
12[(AlO
2)
12(SiO
2)
12]
·xH
2O
wherein x is from about 20 to about 30, especially about 27. This material is known
as Zeolite A. Preferably, the aluminosilicate has a particle size of about 0.1-10
microns in diameter.
[0096] Specific examples of polyphosphates are the alkali metal tripolyphosphates, sodium,
potassium and ammonium pyrophosphate, sodium and potassium and ammonium pyrophosphate,
sodium and potassium orthophosphate, sodium polymeta phosphate in which the degree
of polymerization ranges from about 6 to about 21, and salts of phytic acid.
[0097] Examples of phosphonate builder salts are the water-soluble salts of ethane I - hydroxy-1,
1-diphosphonate particularly the sodium and potassium salts, the water-soluble salts
of methylene diphosphonic acid e.g. the trisodium and tripotassium salts and the water-soluble
salts of substituted methylene diphosphonic acids, such as the trisodium and tripotassium
ethylidene, isopyropylidene benzylmethylidene and halo methylidene phosphonates. Phosphonate
builder salts of the aforementioned types are disclosed in U.S. Patent Nos. 3,159,581
and 3,213,030 issued December 1, 1964 and October 19, 1965, to Diehl; U.S. Patent
No. 3,422,021 issued January 14, 1969, to Roy; and U.S. Patent Nos. 3,400,148 and
3,422,137 issued September 3, 1968, and January 14, 1969 to Quimby.
[0098] Organic detergent builders preferred for the purposes of the present invention include
a wide variety of polycarboxylate compounds. As used herein, "polycarboxylate" refers
to compounds having a plurality of carboxylate groups, preferably at least 3 carboxylates.
[0099] Polycarboxylate builder can generally be added to the composition in acid form, but
can also be added in the form of a neutralized salt. When utilized in salt form, alkali
metals, such as sodium, potassium, and lithium, or alkanolammonium salts are preferred.
[0100] Included among the polycarboxylate builders are a variety of categories of useful
materials. One important category of polycarboxylate builders encompasses the ether
polycarboxylates. A number of ether polycarboxylates have been disclosed for use as
detergent builders. Examples of useful ether polycarboxylates include oxydisuccinate,
as disclosed in Berg, U.S. Patent 3,128,287, issued April 7, 1964, and Lamberti et
al., U.S. Patent 3,635,830, issued January 18, 1972.
[0101] A specific type of ether polycarboxylates useful as builders in the present invention
also include those having the general formula:
CH(A)(COOX)-CH(COOX)-O-CH(COOX)-CH(COOX)(B)
wherein A is H or OH; B is H or -O-CH(COOX)-CH
2(COOX); and X is H or a salt-forming cation. For example, if in the above general
formula A and B are both H, then the compound is oxydissuccinic acid and its water-soluble
salts. If A is OH and B is H, then the compound is tartrate monosuccinic acid (TMS)
and its water-soluble salts. If A is H and B is -O-CH(COOX)-CH
2(COOX), then the compound is tartrate disuccinic acid (TDS) and its water-soluble
salts. Mixtures of these builders are especially preferred for use herein. Particularly
preferred are mixtures of TMS and TDS in a weight ratio of TMS to TDS of from about
97:3 to about 20:80. These builders are disclosed in U.S. Patent 4,663,071, issued
to Bush et al., on May 5, 1987.
[0102] Suitable ether polycarboxylates also include cyclic compounds, particularly alicyclic
compounds, such as those described in U.S. Patents 3,923,679; 3,835,163; 4,158,635;
4,120,874 and 4,102,903.
[0103] Other useful detergency builders include the ether hydroxypolycarboxylates represented
by the structure:
HO-[C(R)(COOM)-C(R)(COOM)-O]
n-H
wherein M is hydrogen or a cation wherein the resultant salt is water-soluble, preferably
an alkali metal, ammonium or substituted ammonium cation, n is from about 2 to about
15 (preferably n is from about 2 to about 10, more preferably n averages from about
2 to about 4) and each R is the same or different and selected from hydrogen, C
1-4 alkyl or C
1-4 substituted alkyl (preferably R is hydrogen).
[0104] Still other ether polycarboxylates include copolymers of maleic anhydride with ethylene
or vinyl methyl ether, 1, 3,5-trihydroxy benzene-2, 4, 6-trisulphonic acid, and carboxymethyloxysuccinic
acid.
[0105] Organic polycarboxylate builders also include the various alkali metal, ammonium
and substituted ammonium salts of polyacetic acids. Examples include the sodium, potassium,
lithium, ammonium and substituted ammonium salts of ethylenediamine tetraacetic acid,
and nitrilotriacetic acid.
[0106] Also included are polycarboxylates such as mellitic acid, succinic acid, oxydisuccinic
acid, polymaleic acid, benzene 1,3,5-tricarboxylic acid, and carboxymethyloxysuccinic
acid, and soluble salts thereof.
[0107] Citrate builders, e.g., citric acid and soluble salts thereof (particularly sodium
salt), are polycarboxylate builders of particular importance for heavy duty liquid
detergent formulations, but can also be used in granular compositions.
[0108] Other carboxylate builders include the carboxylated carbohydrates disclosed in U.S.
Patent 3,723,322, Diehl, issued March 28, 1973.
[0109] Also suitable in the detergent compositions of the present invention are the 3,3-dicarboxy-4-oxa-1,6-hexanedioates
and the related compounds disclosed in U.S. Patent 4,566,984, Bush, issued January
28, 1986. Useful succinic acid builders include the C
5-C
20 alkyl succinic acids and salts thereof. A particularly preferred compound of this
type is dodecenylsuccinic acid. Alkyl succinic acids typically are of the general
formula R-CH(COOH)CH
2(COOH) i.e., derivatives of succinic acid, wherein R is hydrocarbon, e.g., C
10-C
20 alkyl or alkenyl, preferably C
12-C
16 or wherein R may be substituted with hydroxyl, sulfo, sulfoxy or sulfone substituents,
all as described in the above-mentioned patents.
[0110] The succinate builders are preferably used in the form of their water-soluble salts,
including the sodium, potassium, ammonium and alkanolammonium salts.
[0111] Specific examples of succinate builders include: laurylsuccinate, myristylsuccinate,
palmitylsuccinate, 2-dodecenylsuccinate (preferred), 2-pentadecenylsuccinate, and
the like. Laurylsuccinates are the preferred builders of this group, and are described
in European Patent Application 0,200,263, published November 5, 1986.
[0112] Examples of useful builders also include sodium and potassium carboxymethyloxymalonate,
carboxymethyloxysuccinate, cis-cyclo-hexane-hexacarboxylate, cis-cyclopentane-tetracarboxylate,
water-soluble polyacrylates (these polyacrylates having molecular weights to above
about 2,000 can also be effectively utilized as dispersants), and the copolymers of
maleic anhydride with vinyl methyl ether or ethylene.
[0113] Other suitable polycarboxylates are the polyacetal carboxylates disclosed in U.S.
Patent 4,144,226, Crutchfield et al., issued March 13, 1979. These polyacetal carboxylates
can be prepared by bringing together, under polymerization conditions, an ester of
glyoxylic acid and a polymerization initiator. The resulting polyacetal carboxylate
ester is then attached to chemically stable end groups to stabilize the polyacetal
carboxylate against rapid depolymerization in alkaline solution, converted to the
corresponding salt, and added to a surfactant.
[0114] Polycarboxylate builders are also disclosed in U.S. Patent 3,308,067, Diehl, issued
March 7, 1967. Such materials include the water-soluble salts of homo- and copolymers
of aliphatic carboxylic acids such as maleic acid, itaconic acid and methylenemalonic
acid.
[0115] Other organic builders known in the art can also be used. For example, monocarboxylic
acids, and soluble salts thereof, having long chain hydrocarbyls can be utilized.
These would include materials generally referred to as "soaps." Chain lengths of C
10-C
20 are typically utilized. The hydrocarbyls can be saturated or unsaturated.
[0116] Other optional ingredients include soil release agents, chelating agents, clay soil
removal/anti redeposition agents, polymeric dispersing agents, bleaches, brighteners,
suds suppresors, solvents and aesthetic agents.
[0117] The detergent composition herein can be formulated as a variety of compositions,
for instance as laundry detergents as well as hard surface cleaners or dishwashing
compositions.
[0118] The compositions according to the present invention are further illustrated by the
following examples.
EXAMPLE I
[0119] The following compositions are made by combining the listed ingredients in the listed
proportions. In this example, one or more of the following peptide aldehydes are used:
Peptide aldehyde 1: CH3O-(O)C-Phe-Gly-Ala-LeuH
Peptide aldehyde 2: CH3N-(O)C-Phe-Gly-Ala-LeuH
Peptide aldehyde 3: CH3O-(O)C-Phe-Gly-Ala-PheH
Peptide aldehyde 4: CH3N-(O)C-Phe-Gly-Ala-PheH
Peptide aldehyde 5: CH3SO2Phe-Gly-Ala-Leu-H
Peptide aldehyde 6: CH3SO2Val-Ala-Leu-H
Peptide aldehyde 7: C6H5CH2O(OH)(O)P-Val-Ala-Leu-H
Peptide aldehyde 8: CH3CH2SO2-Phe-Gly-Ala-Leu-H
Peptide aldehyde 9: C6H5CH2SO2-Val-Ala-Leu-H
Peptide aldehyde 10: C6H5CH2O(OH)(O)P-Leu-Ala-Leu-H
Peptide aldehyde 11: C6H5CH2O(OH)(O)P-Phe-Ala-Leu-H
Peptide aldehyde 12: CH3O(OH)(O)P-Leu-Gly-Ala-Leu-H.
| Compositions |
A |
B |
C |
D |
E |
F |
| Linear alkyl benzene sulfonic acid |
8.5 |
15 |
6.5 |
10 |
12.5 |
4 |
| Sodium C12-15 alkyl sulfate |
1 |
2 |
1 |
2 |
-- |
-- |
| C14-15 alkyl 2.5 times ethoxylated sulfate |
10 |
5 |
10.5 |
-- |
11 |
9 |
| C12 glucose amide |
-- |
-- |
9 |
-- |
-- |
5 |
| C12-15 alcohol 7 times ethoxylated |
3 |
10 |
4 |
7 |
2.5 |
-- |
| Fatty acid |
2 |
5 |
5 |
4 |
2 |
2 |
| Citric acid |
6 |
7 |
4 |
6 |
4 |
5 |
| C12-14 alkenyl substituted, succinic acid |
-- |
6 |
-- |
5 |
-- |
6 |
| Sodium hydroxide |
2 |
6 |
2 |
4 |
1 |
1.5 |
| Ethanol |
2 |
1.5 |
2 |
4 |
2 |
1.5 |
| Monoethanolamine |
6 |
5 |
4 |
-- |
-- |
-- |
| 1,2-Propanediol |
12 |
10 |
5 |
5 |
4 |
6 |
| Amylase (143 KNU/g) |
- |
-- |
0.1 |
-- |
-- |
0.2 |
| Lipolase® (100KLU/g commercial solution) |
0.5 |
0.2 |
0.5 |
0.5 |
0.4 |
-- |
| Protease B (34 g/L commerical solution) |
0.9 |
-- |
0.5 |
-- |
1.2 |
-- |
| Savinase® (commercial solution) |
-- |
0.3 |
-- |
0.4 |
0.2 |
0.3 |
| Carezyme® |
0.5 |
1 |
0.8 |
- |
0.2 |
0.8 |
| Peptide aldehydes 1-12 |
0.009 |
0.005 |
0.001 |
0.0005 |
0.0011 |
0.1 |
| Calcium Ions |
0.01 |
0.5 |
0.1 |
0.05 |
0.9 |
0.25 |
| Water and minors |
Balance to 100% |
EXAMPLE II
[0120] The following formula is tested for % of protease activity remaining. Combinations
of 0%, 0.1%, 0.2%, and 0.3% Ca
++ (from CaCl
2) and 0%, 0.0006%, 0.00125%, and 0.0025% peptide aldehyde (Synthesis Example 6) are
used. Products are held at 32,2°C (90°F) and assayed at weekly intervals for 42 days.
| Component |
wt(%) |
| Alkyl, 1.4 ethoxylated, sulfate |
30 |
| Amine oxide |
6 |
| Polyhydroxy fatty acid amide |
4 |
| Nonionic surfactant (C11E9) |
5 |
| Mg ion from MgCl2 |
1 |
| Ca ion from CaCl2 |
see chart below |
| Peptide aldehyde* |
see chart below |
| Sodium xylene sulfonate |
4 |
| Solvent |
6 |
| Water |
to 100% |
| pH |
to 8 |
| *Peptide Aldehydes of Synthesis Example 6. |
EXAMPLE III
[0121] Results showing the percent protease activity remaining after 42 days at 32,2°C (90°F.)
0.01% Protease B enzyme is used.
| Calcium Ion |
Peptide Aldehyde |
| -- |
0% |
0.0006% |
0.00125% |
0.0025% |
| 0% |
48 |
71 |
75 |
86 |
| 0.1% |
52 |
84 |
92 |
87 |
| 0.2% |
53 |
85 |
98 |
100 |
| 0.3% |
60 |
80 |
98 |
92 |
EXAMPLE IV
[0122] The following compositions are made by combining the listed ingredients in the listed
proportions.
| Ingredients |
A(wt%) |
B(wt%) |
C(wt%) |
D(wt%) |
| LAS |
0 |
0 |
0 |
12 |
| AExS1 |
22.1 |
24.7 |
33.5 |
3 |
| Polyhydroxy fatty acid amide |
4.6 |
1.2 |
4.2 |
0 |
| Amine Oxide |
4.6 |
1.2 |
4.8 |
0 |
| Betaine |
0 |
1.2 |
0 |
0 |
| Nonionic Surfactant |
6.7 |
4.1 |
0 |
0 |
| Mg(OH)2 |
0.5 |
0.5 |
0.7 |
0 |
| Ca ion from CaCl2 |
0.1 |
0.3 |
0.4 |
0.1 |
| Calcium xylene sulfonate |
4.5 |
0 |
4 |
0 |
| Polyethylene glycol |
3 |
0 |
0 |
0 |
| Polypropylene glycol 2000 |
1.5 |
0 |
0 |
0 |
| Balance, water |
to 100% |
to 100% |
to 100% |
to 100% |
| Protease A or Protease B |
0.001-0.01 |
0.001-0.01 |
0.005-0.01 |
0.0003-0.01 |
| Peptide Aldehydes2 |
0.00025-0.0025 |
0.00025-0.0025 |
0.00025-0.0025 |
0.00125-0.0025 |
| 1 x= the degree of ethoxylation. The average degree of ethoxylation for the compositions
are: A=2.2, B=0.6, C=1.4, D=2.2. |
| 2 The peptide aldehydes of Synthesis Example 6 are used herein. |